Cargando…

Correlation of serum IGF-1, AGEs and their receptors with the risk of colorectal cancer in patients with type 2 diabetes mellitus

BACKGROUND: According to epidemiological evidence, people with type 2 diabetes mellitus have a higher risk of developing colorectal cancer. OBJECTIVE: To examine the relationship between colorectal cancer (CRC) and serum levels of IGF-1, IGF-1R, AGEs,RAGE and sRAGE in patients with type 2 diabetes....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zeng, Hong, Qiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986935/ https://www.ncbi.nlm.nih.gov/pubmed/36890832 http://dx.doi.org/10.3389/fonc.2023.1125745

Ejemplares similares

The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy
por: Vigneri, Paolo Giovanni, et al.
Publicado: (2015)

Improvement of Diabetes Mellitus After Colorectal Cancer Surgery: A Retrospective Study of Predictive Factors For Type 2 Diabetes Mellitus Remission and Overall Survival
por: Peng, Dong, et al.
Publicado: (2021)

The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Marked paper: Type 2 diabetes mellitus indicates increased postoperative complications and poor prognosis in colorectal cancer patients receiving curative surgery
por: Liu, Daoli, et al.
Publicado: (2023)

Risk factors for elevated serum colorectal cancer markers in patients with type 2 diabetes mellitus
por: Guo, Jingjing, et al.
Publicado: (2020)

Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development
por: Duan, Xiaoye, et al.
Publicado: (2021)

A Correlation Study of Prognostic Risk Prediction for Colorectal Cancer Based on Autophagy Signature Genes
por: Zhao, Haibi, et al.
Publicado: (2021)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)

Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case–Control Studies from Italy and Spain
por: Rosato, Valentina, et al.
Publicado: (2016)

Correlation analysis of serum IGF-1 and IL-6 and urinary albumin/creatinine ratio in patients with type 2 diabetic kidney disease
por: Liu, Guan-Wen, et al.
Publicado: (2022)

Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis
por: Njoku, Kelechi, et al.
Publicado: (2022)

Obesity, Type 2 Diabetes, and Cancer Risk
por: Scully, Tiffany, et al.
Publicado: (2021)

Pro-tumorigenic role of type 2 diabetes-induced cellular senescence in colorectal cancer
por: Melia, Francesco, et al.
Publicado: (2022)

Expression of ZNF281 in colorectal cancer correlates with response to radiotherapy and survival
por: Qin, Changjiang, et al.
Publicado: (2023)

Cross-Talk between Adiponectin and IGF-IR in Breast Cancer
por: Mauro, Loredana, et al.
Publicado: (2015)

Correlation of Serum Adiponectin and Leptin levels in Obesity and Type 2 Diabetes Mellitus
por: Diwan, Arundhati G., et al.
Publicado: (2018)

Glioma Cells With Genetically Engineered IGF-I Receptor Downregulation Can Persist in the Brain in a Dormant State
por: Samani, Amir A., et al.
Publicado: (2020)

Correlation of Serum IGF-1R, VEGF, and ET Levels with Bone Mineral Density in Type 2 Diabetic Mellitus Patients Treated with Metformin Plus α-Glucosidase Inhibitors
por: Chen, Xue, et al.
Publicado: (2022)

Case report: Type 2 diabetes mellitus with plantar malignant melanoma: Report of two cases
por: Huang, Bi-Ling, et al.
Publicado: (2023)

Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus
por: Kim, Min Sun, et al.
Publicado: (2015)

Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment
por: Lodhia, Kunal Amratlal, et al.
Publicado: (2015)

Correlation Between IGFs-Related Proteins Expression and Incidence of Colorectal Cancer in Diabetic Patients and Related Mechanisms
por: Han, Xu, et al.
Publicado: (2016)

Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer
por: Li, Longhai, et al.
Publicado: (2019)

m(6)A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma
por: Wu, Hansheng, et al.
Publicado: (2022)

Serum IGF-1 in patients with rheumatoid arthritis: correlation with disease activity
por: Lee, Hanna, et al.
Publicado: (2022)

Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
por: Renehan, A G, et al.
Publicado: (2000)

HOXB4 Mis-Regulation Induced by Microcystin-LR and Correlated With Immune Infiltration Is Unfavorable to Colorectal Cancer Prognosis
por: Wang, Lingqiao, et al.
Publicado: (2022)

LC–MS-based serum metabolomics analysis for the screening and monitoring of colorectal cancer
por: Yi, Yanan, et al.
Publicado: (2023)

Estrogen Receptors and Their Implications in Colorectal Carcinogenesis
por: Caiazza, Francesco, et al.
Publicado: (2015)

Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer
por: Hu, Yue, et al.
Publicado: (2022)

Receptor–ligand pair typing and prognostic risk model of response or resistance to immune checkpoint inhibitors in lung adenocarcinoma
por: Mao, Shengqiang, et al.
Publicado: (2023)

Serum ferritin as a risk factor for type 2 diabetes mellitus, regulated by liver transferrin receptor 2
por: Zhang, Rui, et al.
Publicado: (2021)

Correlation analysis of IGF-1, ZAG, nesfatin-1, HbA(1c) levels, and type 2 diabetes mellitus complicated with hypothyroidism
por: He, Shuangling, et al.
Publicado: (2021)

IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai
por: Probst-Hensch, N M, et al.
Publicado: (2001)

Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
por: Liu, Huidi, et al.
Publicado: (2020)

Serum Chemokine CXCL7 as a Potential Novel Biomarker for Obstructive Colorectal Cancer
por: Li, Longhai, et al.
Publicado: (2021)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
por: Gao, Shunhui, et al.
Publicado: (2023)

Evaluating Neighborhood Correlates and Geospatial Distribution of Breast, Cervical, and Colorectal Cancer Incidence
por: Torres, Aracelis Z., et al.
Publicado: (2018)

Hypoxia Correlates With Poor Survival and M2 Macrophage Infiltration in Colorectal Cancer
por: Qi, Lina, et al.
Publicado: (2020)

Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation
por: de Kort, Sander, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_60ktenkauak545h2addjj5cs73